OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 02, 2010
Clinical studies have shown that treatment with thymosin alpha 1 increases response to vaccination.
The viscosity of oily emulsions can reduce filter capacity and bacterial retention.
Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.